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Summary 
 
Background In the absence of a vaccine or effective treatment for COVID-19, countries have 
adopted Non-Pharmaceutical Interventions (NPIs) such as social distancing and full lockdown. 
An objective and quantitative means of monitoring the impact and response of these 
interventions at a local level is urgently required. Here we explore the utility of the recently 
developed open-source mobile health platform RADAR-base as a toolbox to test the effect 
and response to NPIs aimed at limiting the spread of COVID-19. 
 
Methods We included 1062 participants recruited in Italy, Spain, Denmark, the UK, and the 
Netherlands. We derived features from the phone and wearable device for length of time 
spent at home, distance travelled from home, heart rate, sleep, and patterns of phone use. 
We visualised data using time series plots and performed statistical tests to assess differences 
in behaviour during baseline, pre-, and post-lockdown periods. 
 
Findings We found significant changes in behaviours between baseline/pre-lockdown and 
post-lockdown for all features except total sleep duration. In general, participants spent more 
time at home, travelled much less, and were more active on their phones, interacting with 
others by using social apps. Nevertheless, the response across nations differed with Denmark 
showing attenuated changes in behaviour. 
 
Interpretation Differences in the extracted features by country may reflect variations in 
communication and implementation of different NPIs as well as cultural differences. We have 
demonstrated that generalised open-source mobile health monitoring platforms such as 
RADAR-base which leverages data from wearables and mobile technologies are valuable tools 
for helping understand the behavioural impact of public health interventions implemented in 
response to infectious outbreaks such as COVID-19. 
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1. Introduction 
On 11 March 2020, the World Health Organisation (WHO) declared the rapidly spreading 
SARS-CoV-2 virus outbreak a pandemic. This novel coronavirus is the cause of a contagious 
acute respiratory disease (COVID-19), which was first reported in Wuhan, Hubei Province, 
China.1–3 As of 17 April 2020, it had infected over two million people and spread to 210 
countries and territories around the world. While precise statistics on mortality are being 
determined, COVID-19 can be deadly with an estimated 1% case fatality rate, and this rate 
increases dramatically for the elderly and vulnerable who have underlying health problems.4,5 
The outbreak of COVID-19 has placed an unprecedented burden on healthcare systems in 
most-affected countries and has resulted in considerable economic losses and possible deep 
global recession.6,7  
 
To date, there is no vaccine or effective treatment. The widely adopted strategy has been the 
use of Non-Pharmaceutical Interventions (NPIs) such as social distancing and even full 
lockdown in order to control the spread of the virus and ease pressure on health and care 
systems.8,9 NPIs have been implemented in many countries including China, Italy, Spain, the 
United Kingdom (UK), and the Netherlands. These measures have been shown to considerably 
reduce the new confirmed cases in China and South Korea, among others.8 Key to the success 
of NPIs is the timing of these interventions and the response of the population, both of which 
might differ among countries, and could necessitate further interventions in the case of low 
compliance either nationally or locally. Therefore, we urgently require an objective and 
quantitative way to monitor population behaviour to assess the impact and response of such 
interventions. Additionally, we need to monitor for the potential effects of a rebound in cases 
in the winter months as social distancing measures are relaxed in order to strategise and 
understand where course corrections are required. Similarly, understanding potential 
seasonal forcing of COVID-19 will require a good understanding of the effects of different NPIs 
so they can be factored out. 
 
The increasing availability of wide-bandwidth mobile networks, smartphones, and wearable 
sensors makes it possible to collect near-real-time high-resolution datasets from large 
numbers of participants and greatly facilitates remote monitoring of behaviour.10–12 By 
leveraging sensor modalities in smartphones which includes Global Positioning System (GPS) 
tracking, and Fitbit devices which includes step counts and heart rate, it is possible to access 
mobility and even wellness for the population. To manage the data collected in multiple 
sensor modalities and mobile devices, platforms such as the open-source RADAR-base (radar-
base.org) mobile health platform have been developed.13 This platform has been used to 
enable remote monitoring in a range of use cases including central nervous system diseases 
(major depressive disorder (MDD), epilepsy and multiple sclerosis (MS)) as part of the IMI2 
RADAR-CNS major programme (radar-cns.org).14  
 
In this paper, we explore the utility of the RADAR-base platform as a toolbox to test the effect 
and impact of NPIs aimed at limiting the spread of infectious diseases such as COVID-19. 
Specifically, we investigate parameters derived from smartphones including GPS and phone 
usage, and from wearable Fitbit devices including step counts, heart rate, and sleep patterns, 
which may be altered by changes in lifestyle due to NPIs such as social isolation.  
 
2. Methods 
We leveraged participant data already collected from November 2017 onwards as part of the 
ongoing RADAR-CNS studies.13–15 The RADAR-CNS studies were approved by all local ethics 
committees and all participants signed informed consent.15 We included 1062 participants 
recruited in five European countries: Italy, Spain, Denmark, the UK, and the Netherlands. The 
data have been collected for the purpose of finding new ways of monitoring MDD (Spain (150), 
the Netherlands (103) and the UK (316)) and MS (Milan, Italy (208); Barcelona, Spain (179); 
and Copenhagen, Denmark (106)) using wearable devices and smartphone technology to 
improve patients’ Quality of Life (QOL), and potentially to change the treatment of these and 
other chronic disorders. As we focused on country-level behavioural changes in response to 
the NPIs, we aggregated data collected in Spain and did not focus on analysing differences 
between participants with MDD and MS (except for a sensitivity analysis described in the 
Discussion). Passive participant data were collected through a smartphone and a Fitbit device, 
which included location, activity, sleep, heart rate and phone usage data. These passive data 
required minimal conscious participant engagement and were collected continuously on a 
24/7 basis. In addition to passive data, active data were collected, which required clinicians 
or participants to fill out forms or questionnaires or perform short clinical tests (e.g. speech, 
walking, balance tests). All data were managed by the RADAR-base platform. 
 
To study physical-behavioural changes in response to COVID-19 NPIs, we examined 
participants’ mobility by analysing relative GPS data from smartphones and step count data 
from Fitbit devices. We investigated phone unlock duration and social app duration to study 
social-behavioural changes. Functional measures such as sleep and heart rate from Fitbit 
devices were also analysed to identify possible changes as a result of social distancing.  
 
The smartphone-derived GPS data were sampled at a frequency of five minutes by default, 
with lower frequency dependent on network connectivity. Spurious GPS coordinates were 
identified and removed if they differed from preceding and following coordinates by more 
than five degrees. Home location was determined daily by clustering GPS data between 8 pm 
and 4 am with the mean coordinate of the largest cluster being used. The clustering was 
implemented using Density-Based Spatial Clustering of Applications with Noise.16 A duration 
gated by two adjacent coordinates was regarded as a valid homestay duration on the 
condition that both coordinates were no further than 200 meters from the home location. A 
duration longer than one hour was excluded due to the large proportion of missing data when 
compared to the five-minute sampling frequency. All valid home stay durations between 8 
am and 11 pm were summed to calculate daily homestay. Daily maximum distance from home 
was also computed based on the coordinates in the same period.  
 
In addition to mobility features extracted from smartphones, intraday time series for step 
count was taken from the Fitbit device. Likewise, daily sleep duration was computed as the 
summation of all of the four Fitbit-output stages (AWAKE, LIGHT, DEEP, REM) sampled every 
30 seconds. Finally, daily mean heart rate was calculated by averaging the Fitbit-output heart 
rate readings, sampled every five seconds. 
 
To explore changes in phone usage, daily unlock duration was calculated by summing time 
intervals starting with the unlocked state and ending with the standby state. Single intervals 
longer than four hours were excluded, which might result from a missing standby state or 
unintentionally leaving the phone unlocked. App usage was quantified by classifying apps 
according to categories listed on Google Play. As we were particularly interested in cyber 
social interactions at the time of social distancing, we focused on the daily use time of social 
apps such as Facebook, Instagram, and WhatsApp.  
 
We visualised data using time series plots. The participant daily average and standard 
deviation of each feature were calculated and then plotted. A minimum of 20 participants’ 
data points was a prerequisite for calculation for any given day in order to reduce variance 
and noise. The calculation was implemented after excluding zeros and then excluding values 
below 10% or above 90% on each day. This filtering step helped to mitigate the influence of 
daily outliers caused, for example, by missing data. To facilitate interpretation, we also 
marked time points of public announcements related to lockdown policies.17 
 
To examine physical- and social-behavioural changes induced by the lockdowns, comparisons 
among baseline, pre-, and post-lockdown were carried out using Kruskal-Wallis Tests, where 
the filtered daily average of features for 20 consecutive days were used for each of the three 
groups.18 For the baseline phase, we chose either a 20-day period around one year before the 
lockdowns, or the earliest stable 20-day period. For the pre-lockdown phase, we chose the 
period immediately before the first restrictive measure. For the post-lockdown phase, we 
chose the period following the most recent lockdown. If a significant difference among these 
three groups was found, post-hoc Dunn test was applied with Bonferroni corrections.19 
Boxplots were used to present the results. A p-value < 0·05, after correction, was deemed 
statistically significant. It should be noted that we only applied corrections resulting from 
multiple comparisons for a given feature and a given country.   
 
3. Results 
Time series plots from 1 February 2019 to 12 April 2019 and boxplots of features are shown 
in figure 1-5 and in figure 6 (a-g). Figure 7 shows zoom-in time series plots for figure 3 and 4. 
Most features (except total sleep duration) in baseline and pre-lockdown phases were 
significantly different from post-lockdown phases. In Italy, homestay duration started to 
increase when Lombardy went into lockdown and remained at high levels during the national 
lockdown (z-test statistics = -6·3, p-value < 0·001). Similarly, maximum distance from home 
reduced to very low levels by the end of March (z-test statistics = 6·1, p-value < 0·001) and 
Fitbit step count (z-test statistics = 5·1, p-value < 0·001) and heart rate (z-test statistics = 6·2, 
p-value < 0·001) decreased.  We saw an increase in phone usage, as measured through unlock 
duration (z-test statistics = -5·4, p-value < 0·001) and social app duration (z-test statistics= -
3·7, p-value < 0·001). In Spain, after the lockdown was imposed, there was a sudden and 
marked increase  in homestay duration (z-test statistics = -5·4, p-value < 0·001), reduction in 
maximum distance from home (z-test statistics = 4·5, p-value < 0·001), and reduction in Fitbit 
step count (z-test statistics = 4·4, p-value < 0·001), phone interaction (unlock duration (z-test 
statistics = -6·2, p-value < 0·001) and social app duration (z-test statistics = -4·3, p<0·001)). In 
Denmark, the changes in homestay duration (z-test statistics = -5·4, p-value < 0·001) and Fitbit 
step count (z-test statistics = 2·7, p-value < 0·05) were less evident when restrictions were 
applied, but maximum distance from home dropped sharply (z-test statistics = 4·2, p-value < 
0·001). In the UK, starting from one week before the national recommendation, we saw a 
dramatic increase in homestay duration (z-test statistics = -5·4, p-value < 0·001) and a sharp 
decrease in maximum distance from home (z-test statistics = 4·1, p-value < 0·001). Similar 
changes were observed in phone interaction (unlock duration (z-test statistics= -3·4, p-value 
< 0·01) and social app duration (z-test statistics = -3·0, p-value < 0·01)) and Fitbit step count 
(z-test statistics= 4·1, p-value < 0·001) as well.  In the Netherlands, an  increase in homestay 
duration (z-test statistics= -4·0, p-value < 0·001) and decrease in distance from home  (z-test 
statistics = 4·6, p-value < 0·001) was observed, while the changes in Fitbit step count (z-test 
statistics = 3·8, p-value < 0·001), phone usage (unlock duration (z-test statistics = -3·0, p-value 
< 0·01) and social app duration (z-test statistics = -4·3, p-value < 0·001)) were less obvious 
compared to Italy, Spain and the UK. In Figure 7, we observed marked changes following two 
announcements in addition to national NPIs. In all the time series plots, we observed 
behavioural changes induced by country-specific NPIs and announcements. 
 
4. Discussion 
In this study, we investigated COVID-19 related changes in features derived from mobile 
devices (smartphones and wearable Fitbit devices) of participants recruited from five 
European countries to the RADAR-CNS programme. We studied how lockdown in response to 
the COVID-19 pandemic affected participant behaviour in terms of mobility, functional 
measures, and phone usage.  
 
Our results demonstrate that, in all countries, the lockdown significantly altered lifestyles, 
albeit in different ways. Participants spent more time at home, travelled much less, and were 
more active on their phone, interacting with others by using social apps. However, the 
response across nations differed and may be related to the country-specific  implementations 
of NPIs and perceived degree of risk at the national level. Participants in Spain put a hard stop 
on daily outdoor activity on the day of their national quarantine. In contrast, participants in 
Denmark maintained more of their usual daily routine. These findings are also in line with 
Google mobility reports.20–24 According to the reports updated on 11 April, Italy, Spain, and 
the UK saw no less than a 32% decrease for all mobility trends except residential stay, which 
witnessed over a 19% increase. On the contrary, Denmark and the Netherlands showed more 
than a 33% increase in mobility trends for parks, in addition to no more than an 11% increase 
in residential stays. Furthermore, mobility trends to Grocery and Pharmacy witnessed a 4% 
decrease in the Netherlands and a 4% increase in Denmark.  The difference in the changes in 
the extracted features may reflect difference in communication and implementations of NPIs, 
population reactions to different coping strategies, and cultural differences. 
 
In comparison to Google mobility reports which provide valuable aggregated data for short 
periods, RADAR-base is an open-source highly configurable platform that allows for collecting 
and analysing participant-level data in real-time with a potential for targeted interventions. 
In addition, RADAR-base also collects self-reported questionnaires related to emotional well-
being, functional status, and disease symptom severity of its participants.15 In April 2020, new 
questionnaires are being distributed to specifically assess COVID-19 symptoms and diagnosis 
status of our research participants.  Our future work will use the entirety of these data to gain 
additional insights such as digital early warning signs of COVID-19 and impact of COVID-19 on 
the QOL and clinical trajectory of their primary diagnosis (MDD or MS).  
 
We speculate that the decrease in heart rate may be attributed to the increase in indoor stay 
and greater sedentary behaviour, and the slight increase in total sleep duration. This decrease, 
coupled with an increase in social app duration, could possibly serve as indicators of social 
distancing. Furthermore, it has been shown that an elevated resting heart rate may suggest 
acute infections.25 It would be interesting to infer one’s infection by continuously monitoring 
heart rate, especially when the population remains indoor for a vast majority of the time. 
Such monitoring provides the possibility to generate early warning signals for symptomatic or 
presymptomatic respiratory infections, thereby aiding timely self-isolation or treatment. The 
COVID-19 related questionnaires we are now distributing will allow us to gain a deeper 
understanding of the relationship between mobile devices derived features including heart 
rate/activity and the COVID-19 symptoms.  
 
In addition to changes in trends, we also identified interesting findings that happened over 
very short periods (see figure 7). A dramatic change in unlock duration was observed in 
Denmark around 11 March 2020 which may be related to the announcement of the pending 
lockdown on that day and a 185% increase in the confirmed cases in Denmark on the previous 
day. Another example can be seen just after the mitigation phase was announced in the UK 
on 12 March, in which social distancing was not strongly recommended, some participants 
seemed to isolate themselves voluntarily by staying at home for much longer. This 
observation may also explain the significant difference between the baseline and pre-
lockdown phases and suggests that people may have acted ahead of further government 
restriction. Furthermore, this is accompanied by a marked loss of weekday/weekend periodic 
structure pre/post lockdown period (see figure 7). Together these observations highlight the 
potential of remote monitoring to monitor population reactions to interventions. 
 
There are some issues to consider in relation to this work. Firstly, we only used a limited 
duration of periods (20 days) to compare the behaviour across the three phases. This 
limitation was because lockdowns had only recently been imposed. However, even with these 
short periods, we were still able to detect significant differences among the three phases, 
highlighting the potential advantages of using mobile devices for detecting behaviour changes. 
Future work will focus on collecting and analysing more data as the project data collection is 
ongoing. Second, the participants included in this study have different medical conditions 
(depression or multiple sclerosis), which led to different baseline levels across countries. 
Nevertheless, as the focus of this study is the changes in the pre-, and post-lockdown phases 
relative to the baseline, we were still able to identify and compare the changes induced by 
lockdowns. We also analysed the data collected in Spain split into MDD and MS separately. 
The trends and the statistical differences in all features remained the same except total sleep 
duration. The unsplit case showed statistical significance (z-test statistics = -2·4, p = 0·047), 
while the split case did not. This was probably due to reduced sample size when split into 
MDD and MS. Understanding of any artefacts or effects introduced into the RADAR-CNS data 
by the NPIs will be crucial in RADAR-CNS being able to deliver its aim of identifying signals 
that predict and prevent MDD and MS. Third, on account of requirements for participants’ 
privacy in the RADAR-CNS studies, location data were purposely obfuscated with a 
participant-specific random value preventing precise localisation of the participants, which 
prevented us from taking into account geographic factors within a country. It would be 
interesting to examine how specific regions react to lockdowns when these data are available 
in future work. Fourth, limited sample sizes in certain countries and data loss impacted the 
smoothness of the time series plots. The time series plots for Denmark and the Netherlands 
showed relatively large variance particularly in the early phase as these sites have only 
recently begun recruiting. Several dips and spikes in step counts and heart rate were seen in 
all countries during July and August. This was due to the fact that we had some data loss due 
to connectivity issues with the Fitbit server during this time. Fifth, we only explored a subset 
of features that can be derived from smartphones and Fitbit wearable devices. Future work 
will investigate whether other features offer additional information for a more complete 
description of lifestyle changes. Finally, national policy and participant acceptability 
determine what value is placed on privacy and therefore, what level of monitoring is 
acceptable. At one end of the spectrum, we have seen individual-level contact tracing mobile 
apps and at the other privacy-preserving approaches that only allow population intervention 
monitoring. We were able to demonstrate value in the data collected even under strict 
privacy-preserving conditions. 
 
5. Conclusions 
 
Using individual-level data from smartphones and wearable devices over a one-year period 
covering the outbreak and subsequent spread of the COVID-19 pandemic across five 
European countries, we were able to detect and monitor the physical-behavioural and social-
behavioural changes in response to the NPIs. We found that most participants spent more 
time at home, travelled much less and were more active on their phone, in particular, 
interacting with others using social apps. We also showed the different responses across 
countries with Denmark showing attenuated responses to NPIs compared to other countries. 
Furthermore, we were able to identify features such as homestay duration, maximum 
distance from home and step count which varied significantly as the implementation of NPIs. 
These features could be used as objective measures for evaluating aspects of NPIs 
performance during their introduction and any subsequent relaxation of these measures. This 
work demonstrates the value of a generalised open-source platform such as RADAR-base to 
leverage data from wearables and mobile technologies for understanding behavioural impact 
of public health interventions implemented in response to infectious outbreaks such as 
COVID-19. This ability to monitor response to interventions, in near real time, will be 
particularly important in understanding behaviour as social distancing measures are relaxed 
as part of an COVID-19 exit strategy. Future work will include utilising participants responses 
to COVID-19 related questionnaires, together with an expanded feature set to gain more 
specific understandings into the relationship between mobile devices derived features and 
the COVID-19 symptoms.  
 
 
 
 
 
Figure 1. Time series plots for Milan, Italy (208 participants).  (a): homestay duration, (b): 
maximum distance from home, (c): Fitbit step count, (d): total sleep duration, (e): heart rate, 
(f): unlock duration, (g): social app duration. Solid line: mean, shade: mean ± standard 
deviation. 
  
Figure 2. Time series plots for Spain (329 participants). (a): homestay duration, (b): maximum 
distance from home, (c): Fitbit step count, (d): total sleep duration, (e): heart rate, (f): unlock 
duration, (g): social app duration. Solid line: mean, shade: mean ± standard deviation.  
 
 
Figure 3. Time series plots for Copenhagen, Denmark (106 participants). (a): homestay 
duration, (b): maximum distance from home, (c): Fitbit step count, (d): total sleep duration, 
(e): heart rate, (f): unlock duration, (g): social app duration. Solid line: mean, shade: mean ± 
standard deviation. 
 
 
Figure 4. Time series plots for London, the United Kingdom (316 participants). (a): homestay 
duration, (b): maximum distance from home, (c): Fitbit step count, (d): total sleep duration, 
(e): heart rate, (f): unlock duration, (g): social app duration. Solid line: mean, shade: mean ± 
standard deviation 
 
Figure 5. Time series plot for Amsterdam, the Netherlands (103 participants). (a): homestay 
duration, (b): maximum distance from home, (c): Fitbit step count, (d): total sleep duration, 
(e): heart rate, (f): unlock duration, (g): social app duration. Solid line: mean, shade: mean ± 
standard deviation. 
 
                 (a)                                                                          (b) 
  
       (c)                                                                        (d)            
   
        (e)                                                                        (f) 
   
        (g) 
 
Figure 6. Boxplots for comparisons among baseline, pre- and post-lockdown phases for 
different features. * means p < 0.05, ** means p < 0.01, ** means p < 0.001. (a): homestay 
duration, (b): maximum distance from home, (c): Fitbit step count, (d): total sleep duration, 
(e): heart rate, (f): unlock duration, (g): social app duration.  
 
 
Figure 7. Zoom-in time series plots for Copenhagen, Denmark and the UK. (a): homestay 
duration, (b): maximum distance from home, (c): Fitbit step count, (d): total sleep duration, 
(e): heart rate, (f): unlock duration, (g): social app duration. Solid line: mean, shade: mean ± 
standard deviation. 
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